Acadia Pharmaceuticals Inc (ACAD)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
EcoR1 Capital

Oleg Nodelman

5,991,479 $110,782,447 2.8%
2. 840,453 $15,539,976 +10% 3.98%
3.
Birchview Capital

Matthew Strobeck

250,400 $4,629,896 +5% 3.78%
4.
Ghost Tree Capital

Ken Greenberg And David Kim

225,000 $4,160,250 +350% 1.15%
5. 204,673 $3,784,404 0.09%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$25.65 259,109 Large Shareholder, Director 39,317,673 2023-05-24 Filing
$25.65 24,113 Large Shareholder, Director 3,610,443 2023-05-24 Filing
$25.51 28,878 Large Shareholder, Director 39,058,564 2023-05-24 Filing
$25.51 2,688 Large Shareholder, Director 3,586,330 2023-05-24 Filing
$25.27 218,171 Large Shareholder, Director 39,029,686 2023-05-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.94 3,503 32,053 2024-05-02 Filing
$16.94 3,477 42,133 2024-05-02 Filing
$16.94 1,326 14,370 2024-05-02 Filing
$16.94 11,427 155,231 2024-05-02 Filing
$17.87 17,716 144,267 2024-04-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 13,396,009 $419,429,041 0%
2. 11,410,483 $357,262,222 0%
3. 11,253,551 $352,348,682 5.5%
4. 6,465,026 $202,419,964 0%
5. 5,265,358 $164,858,357 0.01%
News See All